These findings present strong evidence that CML-derived exosomes can serve as reliable vehicles for identifying and detecting the BCR-ABL fusion transcript, offering an innovative, non-invasive platform for molecular diagnostics in CML [121]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.